• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺上皮性肿瘤3种组织学分类和3种分期系统的可重复性及其对预后的影响。

Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.

作者信息

Roden Anja C, Yi Eunhee S, Jenkins Sarah M, Edwards Kelly K, Donovan Janis L, Lewis Jean E, Cassivi Stephen D, Marks Randolph S, Garces Yolanda I, Aubry Marie Christine

机构信息

Departments of *Laboratory Medicine & Pathology ∥Radiation-Oncology Divisions of †Biomedical Statistics and Informatics ‡General Thoracic Surgery §Medical Oncology, Mayo Clinic Rochester, MN.

出版信息

Am J Surg Pathol. 2015 Apr;39(4):427-41. doi: 10.1097/PAS.0000000000000391.

DOI:10.1097/PAS.0000000000000391
PMID:25634747
Abstract

Data regarding the prognostic significance of the histopathologic classifications of thymic epithelial neoplasms are contradictory, perhaps reflecting issues in reproducibility. We studied the effect of reproducibility of 3 histopathologic classifications on prognosis and investigated the interobserver agreement on invasion and its effect on staging and prognosis. A total of 456 patients who underwent surgery for thymic epithelial neoplasm at Mayo Clinic Rochester (1942 to 2008) were staged (modified Masaoka, proposed Moran, proposed IASLC/ITMIG) and independently classified by 3 thoracic pathologists (World Health Organization, proposed Suster & Moran [S&M], and Bernatz). Interobserver agreement was moderate to substantial for all histopathologic classifications (κ values: 0.65, 0.52, 0.74 for World Health Organization, Bernatz, and S&M, respectively). All histopathologic classifications were significant for overall survival (OS) and disease-free survival (DFS) (all reviewers). If adjusted for Masaoka, only Bernatz classification for one reviewer and all histopathologic classifications for another reviewer were significant for OS. Interobserver agreement for invasion was substantial (κ=0.61) and almost perfect for Masaoka, Moran, and IASLC/ITMIG stage (κ values: 0.85, 0.81, and 0.92, respectively). The correlation coefficient for Masaoka and Moran staging was 0.93. Masaoka and IASLC/ITMIG staging were significant for OS and DFS (all reviewers). If adjusted for any histopathologic classification, Masaoka was significant for OS and DFS (all reviewers). In conclusion, reproducibility of histopathologic classifications has some effect on outcome. S&M is the most reproducible classification. Reproducibility of invasion has no effect on the prognostic value of staging. Masaoka, Moran, and IASLC/ITMIG staging are almost perfectly reproducible. The strong correlation between Masaoka and Moran staging suggests similar prognostic strength.

摘要

关于胸腺上皮肿瘤组织病理学分类的预后意义的数据相互矛盾,这可能反映了可重复性方面的问题。我们研究了3种组织病理学分类的可重复性对预后的影响,并调查了观察者间对侵袭的一致性及其对分期和预后的影响。共有456例在梅奥诊所罗切斯特院区(1942年至2008年)接受胸腺上皮肿瘤手术的患者进行了分期(改良马萨oka分期、莫兰提议的分期、国际肺癌研究协会/国际胸腺恶性肿瘤研究组提议的分期),并由3位胸外科病理学家(世界卫生组织、苏斯特和莫兰提议的[S&M]以及贝尔纳茨)进行独立分类。所有组织病理学分类的观察者间一致性为中等至高度(κ值:世界卫生组织、贝尔纳茨和S&M分别为0.65、0.52、0.74)。所有组织病理学分类对总生存期(OS)和无病生存期(DFS)均具有显著意义(所有审阅者)。若根据马萨oka分期进行调整,仅一位审阅者的贝尔纳茨分类以及另一位审阅者的所有组织病理学分类对OS具有显著意义。侵袭的观察者间一致性较高(κ=0.61),而马萨oka、莫兰和国际肺癌研究协会/国际胸腺恶性肿瘤研究组分期的一致性几乎达到完美(κ值分别为0.85、0.81和0.92)。马萨oka和莫兰分期的相关系数为0.93。马萨oka和国际肺癌研究协会/国际胸腺恶性肿瘤研究组分期对OS和DFS均具有显著意义(所有审阅者)。若根据任何组织病理学分类进行调整,马萨oka对OS和DFS均具有显著意义(所有审阅者)。总之,组织病理学分类的可重复性对结果有一定影响。S&M是最具可重复性的分类。侵袭的可重复性对分期的预后价值没有影响。马萨oka、莫兰和国际肺癌研究协会/国际胸腺恶性肿瘤研究组分期几乎具有完美的可重复性。马萨oka和莫兰分期之间的强相关性表明其预后强度相似。

相似文献

1
Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.胸腺上皮性肿瘤3种组织学分类和3种分期系统的可重复性及其对预后的影响。
Am J Surg Pathol. 2015 Apr;39(4):427-41. doi: 10.1097/PAS.0000000000000391.
2
Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.改良的 Masaoka 分期和肿瘤大小是胸腺瘤独立的预后预测因子,改良的 Masaoka 分期优于组织病理学分类。
J Thorac Oncol. 2015 Apr;10(4):691-700. doi: 10.1097/JTO.0000000000000482.
3
Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.胸腺瘤:世界卫生组织组织学分型、Masaoka 分期、重症肌无力之间的相互关系及其独立的预后意义:单中心经验。
Eur J Cardiothorac Surg. 2011 Jul;40(1):146-53. doi: 10.1016/j.ejcts.2010.09.042. Epub 2010 Nov 18.
4
Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival.胸腺恶性肿瘤新 TNM 分期系统的评估:对适应证和生存的影响。
World J Surg Oncol. 2017 Dec 2;15(1):214. doi: 10.1186/s12957-017-1283-4.
5
[Clinical outcome of epithelial tumors of the thymus].[胸腺上皮性肿瘤的临床结局]
Kyobu Geka. 2002 Oct;55(11):936-41.
6
Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.术后放疗对胸腺癌有效,但对Ⅱ期和Ⅲ期胸腺上皮肿瘤中的胸腺瘤无效:日本胸腺研究协会数据库研究
Cancer. 2015 Apr 1;121(7):1008-16. doi: 10.1002/cncr.29166. Epub 2015 Jan 6.
7
[Comparison of the Masaoka-Koga and The IASLC/ITMIG Proposal for The TNM 
Staging Systems Based on the Chinese Alliance for Research in Thymomas (ChART)
Retrospective Database].基于中国胸腺瘤研究联盟(ChART)回顾性数据库的Masaoka-Koga分期系统与国际肺癌研究协会/国际胸腺恶性肿瘤研究组(IASLC/ITMIG)TNM分期系统提案的比较
Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):425-36. doi: 10.3779/j.issn.1009-3419.2016.07.04.
8
Recommendations for the reporting of surgically resected thymic epithelial tumors.手术切除胸腺上皮肿瘤报告的建议。
Hum Pathol. 2009 Jul;40(7):918-23. doi: 10.1016/j.humpath.2009.03.012.
9
Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings.胸腺上皮肿瘤:临床、组织病理学及计算机断层扫描结果中的预后决定因素
Ann Thorac Surg. 2015 Feb;99(2):462-70. doi: 10.1016/j.athoracsur.2014.09.050. Epub 2014 Dec 20.
10
Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.由国际肺癌研究协会分期与预后因素委员会和国际胸腺恶性肿瘤兴趣小组提出的胸腺恶性肿瘤新肿瘤-淋巴结-转移分期系统的临床评估。
Eur J Cardiothorac Surg. 2016 Feb;49(2):574-9. doi: 10.1093/ejcts/ezv389. Epub 2015 Nov 7.

引用本文的文献

1
CECT-based simplified scoring model for differentiating low-risk thymomas from hyper-attenuating thymic cysts: A STARD compliant article.基于CT增强扫描的低风险胸腺瘤与高密度胸腺囊肿鉴别简化评分模型:一篇遵循STARD规范的文章
Medicine (Baltimore). 2025 Sep 5;104(36):e44453. doi: 10.1097/MD.0000000000044453.
2
Clinical significance of positron emission tomography-computed tomography in the classification of thymic tumors.正电子发射断层扫描-计算机断层扫描在胸腺肿瘤分类中的临床意义
Interdiscip Cardiovasc Thorac Surg. 2025 Mar 5;40(3). doi: 10.1093/icvts/ivaf065.
3
Risk stratification of thymic epithelial tumors based on peritumor CT radiomics and semantic features.
基于肿瘤周围CT影像组学和语义特征的胸腺上皮肿瘤风险分层
Insights Imaging. 2024 Oct 22;15(1):253. doi: 10.1186/s13244-024-01798-2.
4
Quantitative CT parameters combined with preoperative systemic inflammatory markers for differentiating risk subgroups of thymic epithelial tumors.定量 CT 参数联合术前全身炎症标志物鉴别胸腺瘤危险亚组。
BMC Cancer. 2023 Nov 27;23(1):1158. doi: 10.1186/s12885-023-11332-0.
5
EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma.EZH2和POU2F3有助于鉴别胸腺癌和胸腺瘤。
Cancers (Basel). 2023 Apr 13;15(8):2274. doi: 10.3390/cancers15082274.
6
The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.胸腺瘤和胸腺癌中胸内胚层标记物表达的临床病理意义。
BMC Cancer. 2023 Feb 16;23(1):161. doi: 10.1186/s12885-023-10619-6.
7
Machine-learning classifiers based on non-enhanced computed tomography radiomics to differentiate anterior mediastinal cysts from thymomas and low-risk from high-risk thymomas: A multi-center study.基于非增强计算机断层扫描影像组学的机器学习分类器用于鉴别前纵隔囊肿与胸腺瘤以及低风险与高风险胸腺瘤:一项多中心研究。
Front Oncol. 2022 Nov 24;12:1043163. doi: 10.3389/fonc.2022.1043163. eCollection 2022.
8
Analysis of Pulmonary Function in Thymoma Subjects: A 20-Year Retrospective Cohort Study.胸腺瘤患者肺功能分析:一项 20 年回顾性队列研究。
Thorac Cardiovasc Surg. 2023 Aug;71(5):425-431. doi: 10.1055/s-0042-1749320. Epub 2022 Jul 27.
9
CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma.CD117、BAP1、MTAP和TdT是用于区分胸腺瘤和胸腺癌的有用免疫组织化学检测组合。
Cancers (Basel). 2022 May 5;14(9):2299. doi: 10.3390/cancers14092299.
10
Micronodular Thymoma with Lymphoid Stroma: A Mediastinal Mass Masquerading as a Pericardial Mass.微结节性胸腺瘤伴淋巴间质:伪装为心包肿块的纵隔肿块。
Methodist Debakey Cardiovasc J. 2021 Oct 19;17(3):18-23. doi: 10.14797/mdcvj.516. eCollection 2021.